CED Cannabis Science Digest: 3 Cannabis Use, Cognition, and Policy Signals Worth Watching
This digest highlights cannabis cognition after cessation alongside young-adult use and policy signals. It preserves three verified lower-certainty cannabis signals worth watching. These insights offer valuable context for clinicians and public health.
Stigma toward individuals with cannabis use disorder across age groups: associations with familiarity and sociodemographic characteristics.
Stigma toward cannabis use disorder varies across age groups, with adolescents facing more stigma than adults. Familiarity with cannabis use or CUD reduces stigmatizing attitudes. Sociodemographic factors also play a role in shaping these perceptions.
Summer Bud Guide
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. IndustryTHCCBDSafetyDosingResearchPolicy Why This Matters Clinicians should understand that patients increasingly make…
Relationships between cannabis use and mental disorders: assessing the coherence of evidence from studies with different methodologies.
Research shows relationships cannabis mental disorders are significant, especially with daily use starting in adolescence. Evidence links cannabis use to psychosis, bipolar disorder, anxiety, and depression. Young people with cannabis use disorder face…
International Cannabis Policies and Their Association with Cannabis Use, Cannabis Use Disorder, and Other Psychiatric Disorders
International cannabis policies shape cannabis use and cannabis use disorder prevalence worldwide. Commercialized legalization is linked to increased cannabis use disorder rates. However, associations with broader psychiatric disorders remain…
Clinical Trial: High Doses of CBD Superior to Placebo in Treating Neuropathic Pain
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDPainResearchNeurologyDosingSafetyPolicy Why This Matters This trial provides clinicians with evidence-based dosing…
Clinical and Sociodemographic Correlates of Poor Medication Adherence in Bipolar Disorder
Poor medication adherence bipolar disorder is linked to factors such as substance use, younger age, and lower illness insight. This review identifies key correlates to guide clinical screening. Addressing these factors may reduce relapse risk in bipolar…
PleoPharma Announces 1st Patient Dosed in Phase 3 Clinical Trial for Cannabis Use Disorder
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyCBDDosingHempIndustry Why This Matters This Phase 3 trial represents progress toward a…
Clinical Phenomenology of Bipolar Disorder With Substance Use Disorders: A Systematic Review.
This systematic review examines bipolar disorder substance use and its clinical effects. Different substances uniquely influence mood episodes, cycling, and recovery in bipolar patients. Understanding these impacts aids clinicians in managing comorbid…
Cannabis Warning Label Regulations and Characteristics in US States with Medical and …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyDosingMental HealthPediatricsTHC Why This Matters Clinicians need standardized, evidence-based…